Actress Christina Applegate, 54, is investigating the potential link between her breast implants and her ongoing pain and fatigue, following a revelation that she had been misdiagnosed with multiple sclerosis (MS) — a condition she was told she had in 2021.
During the November 10 episode of MeSsy, the podcast she co-hosts with actor Jamie-Lynn Sigler, Applegate, who rose to prominence as a teenager in the popular sitcom Married With Children, shared that she recently received a study indicating that symptoms linked to breast implants closely resemble those of MS.
“I can’t help but think, ‘What if they’re leaking and causing harm to me?'” she remarked, expressing her intent to discuss her concerns with her healthcare providers.
-
As Christina Applegate reveals MS misdiagnosis, doctor warns of wrong treatment risks
-
The subject of Lyme disease is littered with misinformation. Celebrities are part of the problem, experts say
In 2008, Applegate underwent a double mastectomy and breast reconstruction after being diagnosed with an early stage of breast cancer and discovering she had a BRCA1 gene mutation, which increases the likelihood of breast and other cancers. On her podcast, she mentioned that it was “past time” to replace her implants.
She has also reported experiencing increasing pain and challenges with mobility in her right shoulder, stating it takes her a minimum of 10 minutes to sit up and rise from bed. These symptoms, she explained, are daunting because “there are so many different factors that could be at play.”
Her inquiry follows a diagnosis in October when physicians informed her that she does not have MS. At that time, Applegate expressed that she felt as if she was back at “Square 1,” with her physical challenges persisting and undergoing evaluations for other potential causes, including rheumatoid arthritis, lupus, and Lyme disease.
Though the origins of Applegate’s symptoms remain unclear, some cases have associated breast implants with health issues, although the condition itself is not thoroughly understood.
Understanding Breast Implant Illness

Breast implant illness, or BII, refers to a range of symptoms reported by some individuals with implants, such as fatigue, cognitive changes, joint pain, and muscle pain. This image features a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)
Breast implant illness, commonly referred to as BII, encompasses a range of symptoms reported by some individuals with implants.
As of December 31, 2025, Health Canada had documented 663 instances of symptoms or ailments associated with breast implants — roughly one report for every 1,025 implants sold in Canada.
Fatigue was the most commonly reported symptom, followed by mood swings, gastrointestinal issues, and cognitive changes. It is important to note that these are reports rather than confirmed cases; Health Canada states that the available data does not determine whether implants caused the symptoms, which may arise from other sources.
The U.S. Food and Drug Administration (FDA) clarifies that BII is not an established medical diagnosis and lacks a specific test. Reports of symptoms like fatigue and joint issues do not indicate their frequency or whether implants are to blame.
Julie Elliott, a Canadian advocate for breast implant illness and implant-associated cancer with the Breast Implant Safety Alliance, who experienced health complications after breast augmentation, informed CBC News that some symptoms reported by individuals with implants can overlap with those of MS.
-
National breast implant registry much needed but long overdue, patients and doctors say
-
Alberta women with breast implant illness urge doctors to warn others of risk
“Chronic fatigue, memory changes, difficulty concentrating, numbness, tingling, nerve pain, muscle weakness, and hair loss — these symptoms are indeed similar to those of MS,” Elliott stated.
However, she cautioned against assuming that Applegate’s implants are the cause of her health issues. “I’m not suggesting that Christina Applegate’s breast implants are the source of her symptoms,” she clarified, stressing that it would be “premature and irresponsible” to jump to conclusions.
“Similar symptoms do not necessarily equate to the same diagnosis,” Elliott remarked. “Every potential cause should be thoroughly explored and not dismissed without proper medical examination.”

Christina Applegate, left, arrives for the 29th Screen Actors Guild Awards in Century City, California, on February 26, 2023. (Valerie Macon/AFP/Getty Images)
Dr. Stephen Nicolaidis, a plastic surgeon from Montreal who has managed over 1,500 patients requiring implant removal, also stressed the importance of exploring other potential causes.
He characterized BII as a “diagnosis of exclusion,” whereby patients must undergo comprehensive evaluations, and if no alternative cause is identified, the possibility of the implants contributing to the issues should be considered.
Nicolaidis noted that common symptoms he encounters include fatigue, hair loss, skin rashes, difficulty breathing, joint and muscle pain, sleep disturbances, and cognitive fog. Some of these can overlap with symptoms of autoimmune disorders.
Referring to Applegate’s reported symptoms, he indicated, “Her symptoms could definitely be linked to her breast implants.” However, the underlying cause of BII remains uncertain, and he pointed out that researchers have yet to provide clear answers regarding how implants might contribute to these symptoms.
There is no definitive test for diagnosing BII, Nicolaidis explained. While imaging may reveal silicone outside an implant, this finding is not essential for someone to report symptoms. He also emphasized that BII differs from implant-associated lymphoma, a type of cancer connected to certain textured implants.
Rupture, Removal, and Future Considerations
A rupture or leak presents a different concern from BII. The FDA identifies rupture and deflation as potential complications associated with implants and advises patients to consult with their healthcare provider regarding any new or unusual breast changes.
Likewise, Health Canada recommends that individuals with implants routinely check for unusual breast changes and discuss any signs or symptoms with a physician. Decisions regarding whether to keep, replace, or remove implants should be made in conjunction with a clinician, taking into account individual symptoms, potential causes, and surgical risks, according to the agency.
They do not recommend proactive implant removal due to associated surgical risks and advise those experiencing symptoms to address them with a healthcare provider.
-
Struggling with pain for years, N.S. woman heads to Montreal for breast implant removal
-
Video
The costly, complex and dangerous world of removing medical devices | The Implant Files
Nicolaidis encouraged individuals with symptoms to pursue a comprehensive medical assessment. If no other causes are identified, they can explore whether implants might be a contributing factor and discuss options with their healthcare providers.
He ceased placing breast implants in 2021, believing their risks often outweighed the benefits, and now primarily focuses on implant removal. He noted that removal does not guarantee resolution of symptoms. Some patients he has treated with MS have reported only marginal improvement, and those with diagnosed autoimmune conditions may still require medical treatment following explant surgery.
Elliott expressed that symptoms related to implants deserve serious consideration, recognizing that their origins are not fully understood. She urged patients to seek balanced, evidence-based information and monitor changes in their health closely.
“The absence of definitive answers does not mean women’s experiences should be overlooked,” she asserted.
